Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Lonza Group    LONN   CH0013841017

LONZA GROUP

(LONN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
05/25/2020 05/26/2020 05/27/2020 05/28/2020 05/29/2020 Date
500.8(c) 485.8(c) 462.9(c) 478(c) 471.5(c) Last
468 192 453 778 768 052 525 158 631 855 Volume
+3.77% -3.00% -4.71% +3.26% -1.36% Change
More quotes
Financials
Sales 2020 6 170 M 6 421 M 6 421 M
Net income 2020 790 M 822 M 822 M
Net Debt 2020 2 881 M 2 998 M 2 998 M
P/E ratio 2020 43,0x
Yield 2020 0,62%
Sales 2021 6 597 M 6 866 M 6 866 M
Net income 2021 943 M 981 M 981 M
Net Debt 2021 2 341 M 2 437 M 2 437 M
P/E ratio 2021 36,3x
Yield 2021 0,67%
Capitalization 35 027 M 36 433 M 36 456 M
EV / Sales 2020 6,14x
EV / Sales 2021 5,66x
Nbr of Employees 15 468
Free-Float 99,6%
More Financials
Company
Lonza Group is one of the world leaders of the development, production and marketing of chemical products. Net sales break down by family of products and services as follows: - bio-pharmaceuticals and nutritional ingredients (70.4%): exclusive syntheses, microbiological fermentation products , mammalian cell cultures, nutritional ingredients, etc. In addition, the group offers dosage solutions for... 
More about the company
Surperformance© ratings of Lonza Group
Trading Rating : Investor Rating :
More Ratings
Latest news on LONZA GROUP
05/29LONZA : and Sanquin Partner for Commercialization of Specialized MAT Reagents fo..
AQ
05/26Swiss foreign trade hit by coronavirus measures in April
RE
05/19LONZA : Moncef Slaoui to Step Down as Member of the Board of Directors of Lonza ..
AQ
05/18Coronavirus vaccine from Moderna appears safe, shows promise in data from eig..
RE
05/13LONZA : Noga Therapeutics and Lonza Announce Collaboration to Develop Autologous..
AQ
05/12Pfizer to outsource some drug production, focus on coronavirus vaccine
RE
05/01MODERNA : Switzerland's Lonza strike deal on potential COVID-19 vaccine
RE
04/30LONZA GROUP : Ex-dividend day for
FA
04/29LONZA : Announces Results of the 2020 Annual General Meeting All Motions Propose..
AQ
04/28NEWS RELEASE : Lonza Announces Results of the 2020 Annual General Meeting
TE
04/28LONZA GROUP : Dividends
CO
04/28LONZA GROUP : Proxy Statments
CO
04/20LONZA : Reports Solid Q1 2020 Performance, with Segments Continuing to Deliver E..
AQ
04/17GLOBAL MARKETS LIVE: Gilead and Roche come up with new solutions to fight cor..
04/17Lonza focuses on coronavirus projects as epidemic brings in new business
RE
More news
News in other languages on LONZA GROUP
05/29LONZA : and Sanquin Partner for Commercialization of Specialized MAT Reagents fo..
05/29Lonza und Surrozen vereinbaren Zusammenarbeit
05/29Lonza décroche un mandat auprès du californien Surrozen
05/28Lonza und Sanquin arbeiten zur Vermarktung von "Kaninchen-Tests" zusammen
05/28Lonza entame une collaboration avec le néerlandais Sanquin
More news
Chart LONZA GROUP
Duration : Period :
Lonza Group Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LONZA GROUP
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 428,60 CHF
Last Close Price 471,50 CHF
Spread / Highest target 26,8%
Spread / Average Target -9,10%
Spread / Lowest Target -40,0%
EPS Revisions
Managers
NameTitle
Albert M. Baehny Chairman & Chief Executive Officer
Rodolfo Savitzky Chief Financial Officer
Werner J. Bauer Independent Director
Barbara May Richmond Independent Director
Juergen B. Steinemann Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
LONZA GROUP33.49%36 433
IQVIA HOLDINGS INC.-3.23%28 553
SEATTLE GENETICS, INC.37.59%27 213
MODERNA, INC.214.42%23 913
CELLTRION, INC.17.96%23 085
INCYTE CORPORATION16.71%22 153